Adult Immunization 2015: Another Pearl of Pneumococcal Protection
Authors: Sandra Adamson Fryhofer
Journal: Annals of Internal Medicine (2015)

Editorials3 February 2015Adult Immunization 2015: Another Pearl of Pneumococcal ProtectionSandra Adamson Fryhofer, MDSandra Adamson Fryhofer, MDFrom Emory University, Atlanta, Georgia.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-2547 Annals Author Insight Video - Sandra Adamson Fryhofer, MD In this video, Sandra Adamson Fryhofer, MD, offers additional insight into her editorial, "Adult Immunization 2015: Another Pearl of Pneumococcal Protection." SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Publication of the 2015 update of the Adult Immunization Schedule in this issue (1) marks the 10-year anniversary of the American College of Physicians' (ACP) endorsement of this work from the 15-voting-member Advisory Committee on Immunization Practices (ACIP). The ACIP, whose members are selected by the Secretary of the U.S. Department of Health and Human Services (DHHS), is charged with making vaccine recommendations to control vaccine-preventable disease. Its recommendations must be approved by the Director of the Centers for Disease Control and Prevention (CDC) and the DHHS Secretary (2).This year's Adult Immunization Schedule incorporates only 1 change from 2014: ...References1. Kim DK, Bridges CB, Harriman KH; Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 Years or older, United States, 2015. Ann Intern Med. 2015;162:214-23. doi:10.7326/M14-2755 LinkGoogle Scholar2. ACIP Charter: authority, objective, and description. CDC Web site. Accessed at www.cdc.gov/vaccines/acip/committee/charter.html on 26 October 2014. Google Scholar3. Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al; Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822-5. [PMID: 25233284] MedlineGoogle Scholar4. Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep. 2012;61:394-5. [PMID: 22647745] MedlineGoogle Scholar5. Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ; ACIP Evidence Based Recommendations Work Group (EBRWG). Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine. 2011;29:9171-6. [PMID: 21839794] doi:10.1016/j.vaccine.2011.08.005 CrossrefMedlineGoogle Scholar6. Vaccines, Blood & Biologics: vaccine product approval process. FDA Web site. Accessed at www.fda.gov/biologicsbloodvaccines/developmentapprovalprocess/biologicslicenseapplicationsblaprocess/ucm133096.htm on 26 October 2014. Google Scholar7. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816-9. [PMID: 23051612] MedlineGoogle Scholar8. Bridges CB, Coyne-Beasley T; Advisory Committee on Immunization Practices. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older: United States, 2014. Ann Intern Med. 2014;160:190-7. [PMID: 24658695] doi:10.7326/M13-2826 LinkGoogle Scholar9. Affordable Care Act and Immunization. HHS Fact Sheet. 20 January 2012. Accessed at www.hhs.gov/healthcare/facts/factsheets/2010/09/The-Affordable-Care-Act-and-Immunization.html on 26 October 2014. Google Scholar10. ACIP meeting: discussion at additional meeting on use of pneumococcal vaccines in adults [transcript]. 13 August 2014. Accessed at www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-2014-08.pdf on 16 December 2014. Google Scholar Author, Article, and Disclosure InformationAuthors: Sandra Adamson Fryhofer, MDAffiliations: From Emory University, Atlanta, Georgia.Note: Dr. Fryhofer is the ACP liaison to the ACIP.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-2547.Corresponding Author: Sandra Adamson Fryhofer, MD, Adjunct Associate Professor of Medicine, Emory University School of Medicine, 1938 Peachtree Road, Suite 502, Atlanta, GA 30309. PreviousarticleNextarticle Advertisement Annals Author Insight Video - Sandra Adamson Fryhofer, MD In this video, Sandra Adamson Fryhofer, MD, offers additional insight into her editorial, "Adult Immunization 2015: Another Pearl of Pneumococcal Protection." FiguresReferencesRelatedDetailsSee AlsoAdvisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2015* David K. Kim , Carolyn B. Bridges , and Kathleen H. Harriman , on behalf of the Advisory Committee on Immunization Practices† Metrics Cited byGuías para la inmunización del adolescente y adulto en Colombia. Documento de actualización, 2016 3 February 2015Volume 162, Issue 3Page: 235-236KeywordsDisclosureElderlyFood and Drug AdministrationGrading of Recommendations Assessment Development and EvaluationMedical conditionsMedicarePatient Protection and Affordable Care ActPneumoniaVaccinesYoung adults ePublished: 3 February 2015 Issue Published: 3 February 2015 Copyright & PermissionsCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...